JP2004501093A5 - - Google Patents

Download PDF

Info

Publication number
JP2004501093A5
JP2004501093A5 JP2001580865A JP2001580865A JP2004501093A5 JP 2004501093 A5 JP2004501093 A5 JP 2004501093A5 JP 2001580865 A JP2001580865 A JP 2001580865A JP 2001580865 A JP2001580865 A JP 2001580865A JP 2004501093 A5 JP2004501093 A5 JP 2004501093A5
Authority
JP
Japan
Prior art keywords
carbon atoms
group
alkyl
independently selected
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001580865A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004501093A (ja
JP5186075B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/013550 external-priority patent/WO2001083436A2/en
Publication of JP2004501093A publication Critical patent/JP2004501093A/ja
Publication of JP2004501093A5 publication Critical patent/JP2004501093A5/ja
Application granted granted Critical
Publication of JP5186075B2 publication Critical patent/JP5186075B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001580865A 2000-04-28 2001-04-27 テクネチウム−99m及びレニウムで標識した小型作用剤及び腫瘍の画像化方法 Expired - Fee Related JP5186075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20063300P 2000-04-28 2000-04-28
US60/200,633 2000-04-28
PCT/US2001/013550 WO2001083436A2 (en) 2000-04-28 2001-04-27 Small technetium-99m and rhenium labeled agents and methods for imaging tumors

Publications (3)

Publication Number Publication Date
JP2004501093A JP2004501093A (ja) 2004-01-15
JP2004501093A5 true JP2004501093A5 (enExample) 2008-06-26
JP5186075B2 JP5186075B2 (ja) 2013-04-17

Family

ID=22742530

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001580865A Expired - Fee Related JP5186075B2 (ja) 2000-04-28 2001-04-27 テクネチウム−99m及びレニウムで標識した小型作用剤及び腫瘍の画像化方法

Country Status (8)

Country Link
US (2) US7321027B2 (enExample)
EP (1) EP1276718B1 (enExample)
JP (1) JP5186075B2 (enExample)
AT (1) ATE359998T1 (enExample)
AU (2) AU6968301A (enExample)
CA (1) CA2407592C (enExample)
DE (1) DE60127951T2 (enExample)
WO (1) WO2001083436A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515131B2 (en) 2000-02-22 2003-02-04 Biostream Therapeutics, Inc. Imagining agents for diagnosis of Parkinson's disease
WO2004043380A2 (en) * 2002-11-08 2004-05-27 President And Fellows Of Harvard College Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
JP2009051784A (ja) * 2007-08-28 2009-03-12 Inst Nuclear Energy Research Rocaec 癌を抑制する放射性物質及びその調整方法
WO2010144891A1 (en) * 2009-06-13 2010-12-16 President And Fellows Of Harvard College Compositions and methods for imaging tissues, organs and tumors
US10550139B2 (en) 2014-06-09 2020-02-04 Triad National Security, Llc Polydentate ligands and their complexes for molecular catalysis
WO2015191505A1 (en) * 2014-06-09 2015-12-17 Los Alamos National Security, Llc Polydentate ligands and their complexes for molecular catalysis
WO2015200187A1 (en) 2014-06-27 2015-12-30 Reiley Pharmaceuticals, Inc. Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging
EP3242688B1 (en) 2015-01-09 2020-01-29 Reiley Pharmaceuticals, Inc. Cox-2-targeting, platinum-containing conjugates and their use in the treatment of tumors and cancers
WO2017019664A1 (en) 2015-07-28 2017-02-02 University Of Iowa Research Foundation Compositions and methods of treating cancer
WO2017223428A1 (en) 2016-06-24 2017-12-28 Cornell University Rhenium complexes and methods of use for treating cancer
AU2017281940C1 (en) 2016-06-24 2024-11-07 University Of Iowa Research Foundation Compositions and methods of treating melanoma
US10487100B1 (en) 2017-04-04 2019-11-26 Triad National Security, Llc Macrocyclic ligands and their complexes for bifunctional molecular catalysis
US11529335B2 (en) 2020-07-31 2022-12-20 University Of Iowa Research Foundation Compositions and methods for treating cancer
WO2023009442A1 (en) * 2021-07-26 2023-02-02 Rapid Therapeutic Sciences Laboratories, Inc. Improved process for ph-balanced cbg (# 10)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4638051A (en) * 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals
ZA852981B (en) * 1984-04-30 1985-11-27 Univ Johns Hopkins Brain imaging radiopharmaceuticals
US5136038A (en) * 1984-07-19 1992-08-04 University Of Florida Radiopharmaceuticals and chelating agents useful in their preparation
ZA863205B (en) * 1985-05-01 1987-08-26 Univ New York State Res Found Diagnostic radiopharmaceutical compounds
JPH02180865A (ja) * 1987-12-29 1990-07-13 Nippon Mejifuijitsukusu Kk キレート形成性化合物とその用途
AU3778989A (en) * 1988-04-29 1989-11-29 Mallinckrodt, Inc. Diaminedithiol chelating agents for radiopharmaceuticals
US5919934A (en) * 1997-02-19 1999-07-06 The George Washington University Compounds, compositions, and methods for cancer imaging and therapy

Similar Documents

Publication Publication Date Title
JP2004501093A5 (enExample)
AU2019365377B2 (en) Marking precursor with squaric acid coupling
RU2118325C1 (ru) Комплексы металлов с бициклополиазамакроциклом, способ их получения и фармацевтическая композиция для лечения рака
EP4351663A1 (de) Trislinker-konjugierte dimere markierungsvorläufer und daraus abgeleitete radiotracer
PT87802B (pt) Processo para a preparacao de complexos de rodio com quelantes de poliamina funcionalizada
Chappell et al. Synthesis and evaluation of novel bifunctional chelating agents based on 1, 4, 7, 10-tetraazacyclododecane-N, N′, N ″, N‴-tetraacetic acid for radiolabeling proteins
PL367007A1 (en) Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
EP2536691B1 (en) Bifunctional chelating agents
Drews et al. Synthesis and biological evaluation of technetium (III) mixed-ligand complexes with high affinity for the cerebral 5-HT1A receptor and the alpha1-adrenergic receptor
CA2407592A1 (en) Small technetium-99m and rhenium labeled agents and methods for imaging tumors
JPH03504608A (ja) テトラ‐アザマクロサイクルおよびその製造法
EP4196175A1 (en) Radiopharmaceuticals, uses thereof, and methods for the production thereof
JP2006505616A5 (enExample)
EP0650372A1 (en) Compounds for cancer imaging and therapy
Dhara et al. New oxorhenium (V) complexes with 2N2S donor sets and radiochemical behavior of their technetium analogs
JPH09500899A (ja) 放射性核種錯体を製造するためのトリス(イソニトリル)銅(▲i▼)サルフェート
WO1995004552A2 (en) Radiometal complexes that localise in hypoxic tissue
EP0562054A1 (en) Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
EP2099452B1 (en) Tricarbonyl complexes with tridentate chelators for myocardium imaging
Alberto et al. Diazenide and hydrazide (2−) derivatives of the [Re (CO) 3]+ core
US20030027302A1 (en) Bifunctional chelating agent
AU2002337093B2 (en) Bifunctional chelating agent for actinium
AU2023276835A1 (en) Functionalized bisaminothiol derivatives, complexes with these bisaminothiol derivatives and use of said complexes as diagnostics and therapeutics
WO1994026315A1 (en) Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as radiopharmaceuticals
AU3275293A (en) Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates processes for their preparation, and use as radiopharmaceuticals